ReviewOncotarget2017

Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index.

Chloé Rancoule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.